Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ADAPTIVE BIOTECHNOLOGIES COR
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 202,725 shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), worth $3.3M as of 2025-Q4. The position was increased (++40.2% shares). ADPT represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$3.3M
Current Shares
202,725
Total Value Change
+$3.3M
Total Shares Change
+202,725
Other major holders of ADPT: VIKING GLOBAL INVESTORS LP
Increased |
| 202,725 |
+40.2% |
| $3.3M |
| 0.0% |
| $16.42 |
35 |
| 2025-Q3 | Decreased | 144,635 | -45.8% | $2.2M | 0.0% | $13.46 | 0 |
| 2025-Q2 | Increased | 266,893 | +44.1% | $3.1M | 0.0% | $11.79 | 36 |
| 2025-Q1 | Increased | 185,236 | +56.2% | $1.4M | 0.0% | $7.67 | 36 |
| 2024-Q4 | New | 118,593 | - | $710,965 | 0.0% | $6.11 | 34 |
| 2024-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $3.62 | 0 |